[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-001", "question": "A 28-year-old male with a history of opioid use disorder presents with syncope. He admits to taking 'massive doses' of an over-the-counter anti-diarrheal medication to manage withdrawal symptoms. ECG shows sinus bradycardia at 45 bpm, a QTc interval of 680 ms, and intermittent broad-complex beats. He is hemodynamically stable but lethargic. Magnesium sulfate 2g IV is administered without change in the rhythm. Which of the following is the most appropriate next step in management?", "options": ["Option A: IV Amiodarone infusion", "Option B: IV Isoproterenol infusion", "Option C: IV Physostigmine", "Option D: Synchronized cardioversion", "Option E: IV Calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The patient has loperamide toxicity, which blocks cardiac sodium and potassium channels, causing QTc prolongation and wide-complex dysrhythmias. Unlike congenital Long QT (where isoproterenol is contraindicated), loperamide-induced TdP/QT prolongation is bradycardia-dependent; increasing the heart rate (chemical or electrical overdrive pacing) shortens the QT interval and prevents Torsades de Pointes. Amiodarone prolongs QT and is contraindicated.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To answer this question, I need to analyze the clinical scenario and the ECG findings.\n\nThe patient is a 28-year-old male with opioid use disorder who has taken large doses of an over-the-counter anti-diarrheal medication (likely loperamide) to manage withdrawal. His ECG shows significant QT prolongation (QTc 680 ms), bradycardia, and intermittent broad-complex beats, suggesting potential for torsades de pointes.\n\nMagnesium sulfate has already been administered without effect, which is the first-line treatment for torsades de pointes.\n\nLet's evaluate each option:\n\nA. IV Amiodarone - This would be contraindicated as it can further prolong the QT interval.\n\nB. IV Isoproterenol - This is a beta-adrenergic agonist that increases heart rate and can be used to prevent recurrent torsades de pointes by shortening the QT interval through increasing heart rate.\n\nC. IV Physostigmine - This is an acetylcholinesterase inhibitor used for anticholinergic toxicity, not indicated for this scenario.\n\nD. Synchronized cardioversion - This would be appropriate for unstable tachyarrhythmias, not for bradycardia with QT prolongation.\n\nE. IV Calcium gluconate - While calcium can be used in some toxicological emergencies, it's not the first-line treatment for QT prolongation from loperamide toxicity.\n\nGiven the bradycardia and extreme QT prolongation that hasn't responded to magnesium, increasing the heart rate with isoproterenol would be the most appropriate next step to prevent torsades de pointes.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-002", "question": "A 4-month-old female presents with failure to thrive, hypotonia, and a history of pyridoxine-responsive seizures. Laboratory evaluation reveals hypercalcemia, hypercalciuria, and a suppressed parathyroid hormone (PTH) level. Skeletal survey demonstrates diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses. Serum alkaline phosphatase (ALP) is 15 IU/L (Reference: 150-420 IU/L). Which of the following is the definitive treatment for this condition?", "options": ["Option A: High-dose Vitamin D supplementation", "Option B: Recombinant human parathyroid hormone (Teriparatide)", "Option C: Asfotase alfa", "Option D: Pyridoxine (Vitamin B6) monotherapy", "Option E: Bisphosphonate therapy"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Hypophosphatasia (HPP), caused by a loss-of-function mutation in the ALPL gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Low ALP leads to accumulation of inorganic pyrophosphate (an inhibitor of bone mineralization) and pyridoxal-5'-phosphate (causing B6-dependent seizures due to lack of dephosphorylation). Asfotase alfa is the enzyme replacement therapy. Vitamin D and bisphosphonates are contraindicated as they may worsen hypercalcemia and inhibit mineralization further.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the clinical presentation and laboratory findings.\n\nThe patient presents with:\n- Failure to thrive, hypotonia\n- Pyridoxine-responsive seizures\n- Hypercalcemia and hypercalciuria\n- Suppressed PTH\n- Skeletal abnormalities (demineralization, 'moth-eaten' radiolucencies)\n- Markedly low alkaline phosphatase (15 IU/L vs. normal 150-420 IU/L)\n\nThis clinical picture is consistent with hypophosphatasia, a rare inherited disorder characterized by defective bone and tooth mineralization due to mutations in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase. The extremely low ALP level is the key diagnostic finding.\n\nThe definitive treatment for hypophosphatasia is enzyme replacement therapy with asfotase alfa, which is a recombinant human tissue-nonspecific alkaline phosphatase fusion protein that targets bone tissue.\n\nWhile pyridoxine can help control seizures in these patients (as pyridoxal 5'-phosphate accumulates due to low ALP activity), it doesn't address the underlying enzyme deficiency.\n\nVitamin D supplementation would worsen hypercalcemia, bisphosphonates are contraindicated in hypophosphatasia, and teriparatide would not address the fundamental enzyme deficiency.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-003", "question": "A 68-year-old male presents with recurrent fevers, painful auricular chondritis, pulmonary infiltrates, and macrocytic anemia. He has been treated for 'refractory relapsing polychondritis' without success. Bone marrow biopsy reveals hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells. Which of the following is the most likely diagnosis?", "options": ["Option A: Myelodysplastic Syndrome (MDS) with excess blasts", "Option B: VEXAS syndrome", "Option C: Sweet syndrome", "Option D: Polyarteritis Nodosa", "Option E: Granulomatosis with Polyangiitis"], "answer": "B", "answer_index": 1, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in the UBA1 gene. It presents in older men with inflammatory features (chondritis, vasculitis, fevers) and hematologic abnormalities (macrocytic anemia). The pathognomonic finding is vacuoles in myeloid and erythroid precursors in the bone marrow.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most likely diagnosis, I'll analyze the key clinical features presented in this case.\n\nThe patient has:\n- Recurrent fevers\n- Painful auricular chondritis (suggesting polychondritis)\n- Pulmonary infiltrates\n- Macrocytic anemia\n- \"Refractory relapsing polychondritis\" that hasn't responded to treatment\n- Bone marrow findings: hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells\n\nVEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is characterized by:\n- Systemic autoinflammatory disease\n- Hematologic abnormalities including macrocytic anemia\n- Characteristic vacuoles in myeloid and erythroid precursors\n- Often presents with chondritis, particularly auricular\n- Pulmonary manifestations\n- Typically affects older males\n- Often misdiagnosed as refractory polychondritis\n\nThe bone marrow findings with vacuoles in precursor cells are particularly characteristic of VEXAS syndrome, which is a recently described condition that can manifest with features of polychondritis and systemic inflammation.\n\nThe other options (MDS with excess blasts, Sweet syndrome, Polyarteritis Nodosa, and Granulomatosis with Polyangiitis) don't typically present with the combination of refractory polychondritis and the specific bone marrow findings described.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-004", "question": "A 55-year-old female with chronic malnutrition and a history of chronic acetaminophen use for osteoarthritis presents with altered mental status. Arterial blood gas shows pH 7.28, pCO2 28 mmHg, HCO3 12 mEq/L. The anion gap is 24. Lactate is 0.9 mmol/L, serum ketones are negative, and creatinine is 1.1 mg/dL. Toxic alcohol screen is negative. Which of the following is the most appropriate therapeutic intervention?", "options": ["Option A: IV Fomepizole", "Option B: IV Sodium Bicarbonate", "Option C: N-acetylcysteine", "Option D: Hemodialysis", "Option E: Thiamine and Dextrose"], "answer": "C", "answer_index": 2, "explanation": "This patient has high anion gap metabolic acidosis due to 5-oxoproline (pyroglutamic acid) accumulation. This occurs in the setting of glutathione depletion (malnutrition, acetaminophen use), which disrupts the gamma-glutamyl cycle. N-acetylcysteine replenishes glutathione stores, restoring the feedback loop and halting 5-oxoproline production. Fomepizole is for toxic alcohols, which were ruled out.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To solve this question, I need to analyze the patient's presentation and lab values.\n\nThe patient has:\n- Chronic malnutrition and chronic acetaminophen use\n- Altered mental status\n- Metabolic acidosis (pH 7.28, low HCO3 12 mEq/L, respiratory compensation with low pCO2 28 mmHg)\n- High anion gap (24)\n- Normal lactate (0.9 mmol/L)\n- Negative ketones\n- Normal creatinine (1.1 mg/dL)\n- Negative toxic alcohol screen\n\nThis is a high anion gap metabolic acidosis without evidence of lactic acidosis, ketoacidosis, renal failure, or toxic alcohol ingestion. Given the history of chronic acetaminophen use, this is most consistent with 5-oxoproline (pyroglutamic) acidosis, which can occur with chronic acetaminophen use, especially in malnourished patients.\n\nThe treatment for this condition is N-acetylcysteine, which replenishes glutathione stores and helps resolve the acidosis.\n\nOption A (Fomepizole) is for toxic alcohol ingestion, which was negative.\nOption B (Sodium Bicarbonate) treats acidosis but doesn't address the underlying cause.\nOption D (Hemodialysis) isn't indicated with normal renal function.\nOption E (Thiamine and Dextrose) is for Wernicke's encephalopathy or hypoglycemia.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the clinical presentation and the diagnostic findings.\n\nThe patient has:\n- Amenorrhea and galactorrhea (classic symptoms of hyperprolactinemia)\n- A large 4.5 cm pituitary macroadenoma with cavernous sinus invasion\n- Serum prolactin of 145 ng/mL (elevated above reference range)\n\nThe key consideration here is whether the prolactin level matches the size of the tumor. For a 4.5 cm prolactinoma, we would typically expect much higher prolactin levels (often >1000 ng/mL). The relatively modest elevation to 145 ng/mL raises concern for the \"hook effect\" - an analytical phenomenon where extremely high prolactin levels can paradoxically result in falsely low measurements in standard assays.\n\nGiven the discrepancy between the large tumor size and the moderately elevated prolactin level, the most appropriate next step would be to measure prolactin in diluted serum to rule out the hook effect before proceeding with any invasive management.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-006", "question": "A 60-year-old male with a history of radiation therapy for Hodgkin lymphoma presents with signs of cardiac tamponade. Pericardiocentesis is performed, draining 800 mL of bloody fluid. Following drainage, the intrapericardial pressure drops to 0 mmHg, but the right atrial pressure remains elevated at 18 mmHg with a prominent y-descent that was previously absent. Which of the following is the most likely diagnosis?", "options": ["Option A: Incomplete drainage of the effusion", "Option B: Effusive-constrictive pericarditis", "Option C: Right ventricular infarction", "Option D: Pulmonary embolism", "Option E: Flash pulmonary edema"], "answer": "B", "answer_index": 1, "explanation": "Effusive-constrictive pericarditis is characterized by concurrent tamponade and constriction. The visceral pericardium is thickened and constrictive. Initially, the effusion masks the constriction (tamponade physiology: blunted y-descent). After drainage, the tamponade resolves, but the underlying constriction becomes manifest (elevated RA pressure with prominent y-descent). Treatment requires visceral pericardiectomy.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To solve this question, I need to analyze the patient's presentation and hemodynamic findings after pericardiocentesis.\n\nKey findings:\n- 60-year-old male with history of radiation therapy for Hodgkin lymphoma\n- Presented with cardiac tamponade\n- After pericardiocentesis (800 mL bloody fluid removed):\n  * Intrapericardial pressure normalized to 0 mmHg\n  * Right atrial pressure remains elevated at 18 mmHg\n  * Prominent y-descent that was previously absent\n\nThe normalization of intrapericardial pressure indicates successful drainage of the effusion. However, the persistent elevation of right atrial pressure with a prominent y-descent suggests an underlying constrictive process.\n\nEffusive-constrictive pericarditis is characterized by both pericardial effusion and constriction of the visceral pericardium. After drainage of the effusion, the constrictive component becomes more apparent with persistent elevated right atrial pressures and prominent y-descent (rapid early diastolic filling).\n\nThe history of radiation therapy is particularly relevant as it's a known risk factor for developing pericardial disease, including effusive-constrictive pericarditis.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-007", "question": "A 65-year-old male is admitted to the ICU for sedation and mechanical ventilation. On day 3 of a continuous propofol infusion, he develops new Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3. Labs reveal severe metabolic acidosis (pH 7.18), Lactate 9 mmol/L, and CK 8,000 U/L. Echocardiogram shows new global hypokinesis. Which of the following is the most likely diagnosis?", "options": ["Option A: Acute Anterior ST-Elevation MI", "Option B: Massive Pulmonary Embolism", "Option C: Propofol Infusion Syndrome", "Option D: Brugada Syndrome unmasked by fever", "Option E: Septic Cardiomyopathy"], "answer": "C", "answer_index": 2, "explanation": "Propofol Infusion Syndrome (PRIS) is a rare but lethal complication of high-dose/long-duration propofol. It causes mitochondrial failure leading to rhabdomyolysis, metabolic acidosis, heart failure, and characteristic ECG changes (often Brugada-like pattern: RBBB with coved ST elevation). Immediate cessation of propofol and supportive care is required.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely diagnosis, I'll analyze the key clinical features presented:\n\n1. 65-year-old male on day 3 of continuous propofol infusion\n2. New RBBB with coved ST-segment elevation in V1-V3\n3. Severe metabolic acidosis (pH 7.18)\n4. Elevated lactate (9 mmol/L)\n5. Significantly elevated CK (8,000 U/L)\n6. New global hypokinesis on echocardiogram\n\nThis constellation of findings strongly suggests Propofol Infusion Syndrome (PRIS). PRIS typically presents with:\n- Metabolic acidosis\n- Rhabdomyolysis (elevated CK)\n- Cardiac dysfunction (ECG changes, global hypokinesis)\n- Occurs after prolonged propofol infusion\n\nWhile the ECG changes could suggest anterior STEMI or Brugada syndrome, the combination with severe metabolic acidosis, rhabdomyolysis, and the temporal relationship with propofol infusion makes PRIS the most likely diagnosis.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-008", "question": "A 58-year-old male with dyslipidemia develops proximal muscle weakness and myalgias. His CK is 8,500 U/L. Atorvastatin is discontinued. Two months later, his weakness has progressed, and CK remains elevated at 9,200 U/L. Muscle biopsy shows necrotizing myopathy with minimal inflammation. Testing for anti-HMGCR antibodies is positive. Which of the following is the most appropriate management?", "options": ["Option A: Switch to Rosuvastatin", "Option B: Initiate Coenzyme Q10 supplementation", "Option C: Initiate IVIG and/or systemic immunosuppression", "Option D: Observation for spontaneous resolution", "Option E: Dantrolene sodium"], "answer": "C", "answer_index": 2, "explanation": "This patient has Statin-Associated Autoimmune Myopathy (SAAM), specifically anti-HMGCR positive necrotizing myopathy. Unlike self-limited statin myotoxicity, this is an autoimmune process that progresses despite statin cessation. It requires aggressive immunosuppression (steroids, IVIG, Rituximab, or Methotrexate) to prevent permanent muscle loss.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the clinical presentation and diagnostic findings.\n\nThe patient has:\n- Persistent and worsening proximal muscle weakness despite statin discontinuation\n- Persistently elevated CK levels (8,500 â†’ 9,200 U/L)\n- Muscle biopsy showing necrotizing myopathy with minimal inflammation\n- Positive anti-HMGCR antibodies\n\nThis presentation is consistent with immune-mediated necrotizing myopathy (IMNM), specifically statin-induced anti-HMGCR antibody-positive necrotizing myopathy. This is an autoimmune condition that persists despite statin discontinuation.\n\nLet's evaluate each option:\n\nA. Switch to Rosuvastatin - Inappropriate as any statin would likely worsen the condition.\n\nB. Coenzyme Q10 supplementation - While sometimes used for statin myopathy, it's insufficient for immune-mediated necrotizing myopathy.\n\nC. IVIG and/or systemic immunosuppression - This is the standard treatment for immune-mediated necrotizing myopathy, which requires immunosuppression to control the autoimmune process.\n\nD. Observation for spontaneous resolution - Inappropriate as IMNM typically progresses without treatment.\n\nE. Dantrolene sodium - Used for malignant hyperthermia, not indicated for IMNM.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-009", "question": "A 2-week-old XX infant presents with ambiguous genitalia (virilization). Vital signs reveal a blood pressure of 96/60 mmHg (hypertensive for age). Laboratory evaluation shows Sodium 136 mEq/L and Potassium 2.9 mEq/L. 17-hydroxyprogesterone is elevated. Which of the following enzyme deficiencies is the most likely cause?", "options": ["Option A: 21-hydroxylase deficiency", "Option B: 11-beta-hydroxylase deficiency", "Option C: 17-alpha-hydroxylase deficiency", "Option D: 3-beta-hydroxysteroid dehydrogenase deficiency", "Option E: P450 oxidoreductase deficiency"], "answer": "B", "answer_index": 1, "explanation": "Congenital Adrenal Hyperplasia due to 11-beta-hydroxylase deficiency blocks cortisol synthesis, shunting precursors to androgens (causing virilization in females) and accumulating 11-deoxycorticosterone (DOC). DOC is a potent mineralocorticoid, leading to salt retention, hypertension, and hypokalemia. This distinguishes it from the more common 21-hydroxylase deficiency, which causes salt-wasting (hypotension, hyperkalemia).", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most likely enzyme deficiency, I'll analyze the key findings in this case:\n\n1) 2-week-old XX infant with ambiguous genitalia (virilization)\n2) Hypertension (BP 96/60 mmHg)\n3) Normal sodium (136 mEq/L)\n4) Low potassium (2.9 mEq/L)\n5) Elevated 17-hydroxyprogesterone\n\nThe combination of virilization in a female infant, hypertension, and hypokalemia points toward 11-beta-hydroxylase deficiency. This enzyme deficiency causes:\n- Accumulation of 11-deoxycorticosterone (DOC), which has mineralocorticoid activity leading to hypertension and hypokalemia\n- Elevated 17-hydroxyprogesterone\n- Shunting of precursors to the androgen pathway, causing virilization\n\nIn contrast, 21-hydroxylase deficiency typically presents with salt-wasting (hyponatremia and hyperkalemia) or normal electrolytes, not hypertension and hypokalemia.\n\nThe other options (17-alpha-hydroxylase, 3-beta-hydroxysteroid dehydrogenase, and P450 oxidoreductase deficiencies) don't match this specific clinical picture.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-010", "question": "A 45-year-old male on chronic amiodarone therapy for atrial fibrillation presents with weight loss and palpitations. TSH is <0.01 mIU/L and Free T4 is elevated. He has no neck pain. Thyroid ultrasound with color flow Doppler reveals an absence of vascularity within the thyroid parenchyma. Which of the following is the most appropriate initial treatment?", "options": ["Option A: Methimazole", "Option B: Propylthiouracil", "Option C: Prednisone", "Option D: Radioactive Iodine ablation", "Option E: Potassium Perchlorate"], "answer": "C", "answer_index": 2, "explanation": "This is Type 2 Amiodarone-Induced Thyrotoxicosis (AIT), which is a destructive thyroiditis caused by direct cytotoxic effects of the drug. The key differentiator from Type 1 AIT (Jod-Basedow/iodine-induced synthesis) is the Doppler flow: Type 1 has increased vascularity, while Type 2 has absent vascularity. Type 2 is treated with high-dose glucocorticoids. Thionamides (Methimazole) are ineffective for destructive thyroiditis.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most appropriate initial treatment for this patient, I need to analyze the clinical presentation and diagnostic findings.\n\nThe key features of this case are:\n- 45-year-old male on chronic amiodarone therapy\n- Symptoms of hyperthyroidism (weight loss, palpitations)\n- Biochemical evidence of hyperthyroidism (suppressed TSH, elevated Free T4)\n- No neck pain\n- Thyroid ultrasound showing absence of vascularity within the thyroid parenchyma\n\nThis presentation is consistent with amiodarone-induced thyrotoxicosis (AIT). The absence of vascularity on color flow Doppler suggests Type 2 AIT, which is a destructive thyroiditis caused by direct toxic effects of amiodarone on thyroid follicular cells, rather than increased thyroid hormone production (Type 1 AIT).\n\nFor Type 2 AIT:\n- Antithyroid drugs (methimazole, propylthiouracil) are generally ineffective because the hyperthyroidism is not due to increased hormone synthesis\n- Corticosteroids (prednisone) are the first-line treatment as they reduce inflammation and inhibit peripheral conversion of T4 to T3\n- Radioactive iodine is typically ineffective in Type 2 AIT due to low iodine uptake\n- Potassium perchlorate can be used in Type 1 AIT but is not first-line for Type 2\n\nThe answer is (C)"}]